These IC50 values are comparable to the published data in breast cancer [6] and Jak2/MPL mutant cells (~100 nM) [9], but significantly less than Bcl-6-dependent lymphoma cells ( > 1 μM) [7]. The gene discussed is MPL; the disease is breast cancer.